BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22921522)

  • 1. Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder.
    Haenisch B; Herms S; Mattheisen M; Steffens M; Breuer R; Strohmaier J; Degenhardt F; Schmäl C; Lucae S; Maier W; Rietschel M; Nöthen MM; Cichon S
    J Affect Disord; 2013 Apr; 146(3):438-40. PubMed ID: 22921522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between major depressive disorder and a functional polymorphism of the 5-hydroxytryptamine (serotonin) transporter gene: a meta-analysis.
    Kiyohara C; Yoshimasu K
    Psychiatr Genet; 2010 Apr; 20(2):49-58. PubMed ID: 20016401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined effects of the 5-HTTLPR and 5-HTR1A genes modulates the relationship between negative life events and major depressive disorder in a Chinese population.
    Zhang K; Xu Q; Xu Y; Yang H; Luo J; Sun Y; Sun N; Wang S; Shen Y
    J Affect Disord; 2009 Apr; 114(1-3):224-31. PubMed ID: 18848359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong effects of environmental factors on prevalence and course of major depressive disorder are not moderated by 5-HTTLPR polymorphisms in a large Dutch sample.
    Peyrot WJ; Middeldorp CM; Jansen R; Smit JH; de Geus EJ; Hottenga JJ; Willemsen G; Vink JM; Virding S; Barragan I; Ingelman-Sundberg M; Sim SC; Boomsma DI; Penninx BW
    J Affect Disord; 2013 Mar; 146(1):91-9. PubMed ID: 23021380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele.
    Dorado P; Peñas-Lledó EM; González AP; Cáceres MC; Cobaleda J; Llerena A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):451-3. PubMed ID: 17635185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder.
    Hoefgen B; Schulze TG; Ohlraun S; von Widdern O; Höfels S; Gross M; Heidmann V; Kovalenko S; Eckermann A; Kölsch H; Metten M; Zobel A; Becker T; Nöthen MM; Propping P; Heun R; Maier W; Rietschel M
    Biol Psychiatry; 2005 Feb; 57(3):247-51. PubMed ID: 15691525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the 5-HTTLPR polymorphism in the serotonin transporter gene on major depressive disorder and related comorbid disorders.
    Verhagen M; van der Meij A; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
    Psychiatr Genet; 2009 Feb; 19(1):39-44. PubMed ID: 19125107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis between gene variants of the tyrosine hydroxylase and the serotonin transporter in borderline personality disorder.
    Tadić A; Elsässer A; Storm N; Baade U; Wagner S; Başkaya O; Lieb K; Dahmen N
    World J Biol Psychiatry; 2010 Feb; 11(1):45-58. PubMed ID: 20146650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotype analysis confirms association of the serotonin transporter (5-HTT) gene with schizophrenia but not with major depression.
    Zaboli G; Jönsson EG; Gizatullin R; De Franciscis A; Asberg M; Leopardi R
    Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):301-7. PubMed ID: 17886257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.
    Schneck N; Miller JM; Delorenzo C; Kikuchi T; Sublette ME; Oquendo MA; Mann JJ; Parsey RV
    J Affect Disord; 2016 Jan; 190():494-498. PubMed ID: 26561939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression.
    Brockmann H; Zobel A; Schuhmacher A; Daamen M; Joe A; Biermann K; Schwab SG; Biersack HJ; Maier W; Boecker H
    J Psychiatr Res; 2011 Apr; 45(4):442-51. PubMed ID: 20934189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic variation at the SLC6A4 gene promoter in mother-child pairs with major depressive disorder.
    Mendonça MS; Mangiavacchi PM; De Sousa PF; Crippa JAS; Mendes AV; Loureiro SR; Martín-Santos R; Quirino CR; Kanashiro MM; Rios AFL
    J Affect Disord; 2019 Feb; 245():716-723. PubMed ID: 30447571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of polymorphisms of serotonin transporter promoter (5-HTTLPR) and brain derived neurotrophic factor gene (G196A rs6265) on the risk of major depressive disorder in the Chinese Han population.
    Sun N; Yang CX; Liu ZF; Li XR; Xu Y; Zhang KR
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1852-9. PubMed ID: 27212180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking moderates association of 5-HTTLPR and in vivo availability of serotonin transporters.
    Smolka MN; Reimold M; Kobiella A; Reischl G; Rietschel M; Heinz A
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):171-178. PubMed ID: 30587400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor replication of candidate genes for major depressive disorder using genome-wide association data.
    Bosker FJ; Hartman CA; Nolte IM; Prins BP; Terpstra P; Posthuma D; van Veen T; Willemsen G; DeRijk RH; de Geus EJ; Hoogendijk WJ; Sullivan PF; Penninx BW; Boomsma DI; Snieder H; Nolen WA
    Mol Psychiatry; 2011 May; 16(5):516-32. PubMed ID: 20351714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter gene polymorphisms and treatment-resistant depression.
    Bonvicini C; Minelli A; Scassellati C; Bortolomasi M; Segala M; Sartori R; Giacopuzzi M; Gennarelli M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):934-9. PubMed ID: 20450949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.
    Kishida I; Aklillu E; Kawanishi C; Bertilsson L; Agren H
    Neuropsychopharmacology; 2007 Oct; 32(10):2143-51. PubMed ID: 17299512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder.
    Willeit M; Praschak-Rieder N; Neumeister A; Zill P; Leisch F; Stastny J; Hilger E; Thierry N; Konstantinidis A; Winkler D; Fuchs K; Sieghart W; Aschauer H; Ackenheil M; Bondy B; Kasper S
    Mol Psychiatry; 2003 Nov; 8(11):942-6. PubMed ID: 14593433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype.
    Lazary J; Lazary A; Gonda X; Benko A; Molnar E; Juhasz G; Bagdy G
    Biol Psychiatry; 2008 Sep; 64(6):498-504. PubMed ID: 18486105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.